Business Context and Reporting Period
This Form 8-K is filed by Semper Paratus Acquisition Corporation (not Tevogen Inc.) on September 28, 2023. The registrant is a Cayman Islands-based Special Purpose Acquisition Company (SPAC) with securities listed on The Nasdaq Stock Market LLC under the symbols LGSTU, LGST, and LGSTW.
Key Financial Metrics
This filing does not contain standard financial statements, revenue, profit, cash flow, or debt metrics. The only financial metric disclosed relates to listing compliance:
- Market Value of Listed Securities (MVLS): Greater than $50,000,000.
- Compliance Period: Maintained for ten consecutive business days (September 14 to September 27, 2023).
Material Changes
The primary event reported is the resolution of a listing deficiency. The Company previously received notice on April 7, 2023, of non-compliance with Nasdaq Listing Rule 5450(b)(2)(A) regarding the $50,000,000 MVLS requirement. As of September 28, 2023, Nasdaq confirmed the Company has regained compliance, and the matter is now closed.
Guidance, Outlook, and Risks
The filing contains no management guidance, forward-looking outlook, or discussion of new risks. The document solely addresses the closure of the prior listing compliance issue. No unusual items or contingencies are reported in this specific filing.
Investor Verification Checklist
- Verify the correct registrant name is Semper Paratus Acquisition Corporation, as the input metadata referenced "Tevogen Inc."
- Confirm the current trading status of units (LGSTU), shares (LGST), and warrants (LGSTW) on Nasdaq.
- Review the attached Press Release (Exhibit 99.1) for any additional context regarding the company's business development status.
- Monitor future filings for updates on the Company's search for a target business, as this 8-K does not disclose merger progress.